Abstract
Cancer growth is controlled by cancer cells (cell intrinsic phenomenon), but also by the immune cells in the tumor microenvironment (cell extrinsic phenomenon). Thus cancer progression is mediated by the activation of transcription programs responsible for cancer cell proliferation, but also induced proliferation/activation of immunosuppressive cells such as Th17, Treg or myeloid derived suppressor cells (MDSCs). One of the key transcription factors involved in these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on STAT3 activation in immune cells, and how it impacts on tumor progression.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
C.R. was supported by Ligue contre le cancer comité Grand-Est, F.V. by fellowships from Ligue contre le cancer, H.B. by fellowships from the Conseil Régional Bourgogne/INSERM and F.G. by Fondation ARC, Fondation pour la recherche Médicale, INCA, Ligue contre le Cancer.